Technical Analysis for BFFTF - Biofrontera Ag

Grade Last Price % Change Price Change
grade C 5.5049 -17.52% -1.1697
BFFTF closed down 17.52 percent on Thursday, October 10, 2019, on 6.46 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
See historical BFFTF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -17.52%
Gapped Down Weakness -17.52%
Narrow Range Bar Range Contraction -25.92%
Gapped Up Strength -25.92%
Volume Surge Other -24.59%
Older signals for BFFTF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that result in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos over-the-counter line of skin care cosmetics products. In addition, it is developing Ameluz for the treatment of basal cell carcinoma; BF-derm1 for the treatment of chronic and antihistamine-resistant urticaria; and BF-1 for the prophylactic treatment of migraine. The company offers its products primarily in the United States and Europe. Biofrontera AG has a collaboration and partnership agreement with Maruho Co., Ltd. The company was founded in 1997 and is headquartered in Leverkusen, Germany.
Medicine Medical Specialties RTT Biopharmaceutical Diseases Organ Systems Dermatology Migraine Actinic Keratosis Photodynamic Therapy Carcinoma Keratosis Treatment Of Migraine

Is BFFTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 8.22
52 Week Low 5.5049
Average Volume 12,049
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.6719
Resistance 3 (R3) 5.6904 5.6533 5.6440
Resistance 2 (R2) 5.6533 5.6108 5.6440 5.6347
Resistance 1 (R1) 5.5791 5.5845 5.5606 5.5606 5.6255
Pivot Point 5.5420 5.5420 5.5327 5.5327 5.5420
Support 1 (S1) 5.4678 5.4995 5.4493 5.4493 5.3843
Support 2 (S2) 5.4307 5.4732 5.4214 5.3751
Support 3 (S3) 5.3565 5.4307 5.3658
Support 4 (S4) 5.3380